UPMC And Pitt Develop New Cancer Immunotherapy With Avalon GloboCare
A new collaboration among UPMC Hillman Cancer Center, the University of Pittsburgh and New Jersey-based biotechnology company Avalon GloboCare Corp. (NASDAQ: AVCO) aims to develop new cancerA new collaboration among
UPMC Hillman Cancer Center Recently Announced University Of Pittsburg, Avalon GloboCare To Partner To Develop ‘new cancer immunotherapy approaches and streamline manufacturing processes,’ No Terms Disclosed
https://www.upmc.com/media/news/080221-Hillman-Avalon-CAR-Therapy
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Monday
Monday morning, 285 companies reached new 52-week lows.
Avalon GloboCare Says Generated Revenues Of $1.2M For Three Months Ended Mar. 31, Sees FY21 Sales $5M-$7M
Previously Announced Execution of Definitive Agreement to Acquire SenlangBio
SenlangBio Generated Revenue of USD $1.2 Million for the Three Months Ended March 31, 2021 and Projects $5
Avalon GloboCare Adds Cell Therapy-Based Candidates For Cancer With SenlangBio Acquisition: Highlights
Avalon GloboCare Corp (NASDAQ:AVCO) has agreed to acquire Hebei Senlang Biotechnology, dubbed SenlangBio, a China-based cell therapy company, in an all-stock…
Avalon GloboCare Announces Execution Of Purchase Agreement For Acquisition Of SenlangBio In All Stock Transaction; Will Sell 15.6% Equity Interest In SenlangBio To Institutional Healthcare Investor For $30M
Avalon GloboCare Corp. (NASDAQ:AVCO) ("Avalon" or "the Company"), a clinical-stage global developer of cell-based technologies and therapeutics, today announced that it has entered into a